SOFTELMAN
Business purpose.
Les activités D enseignement et de recherche dans les domaines de la biologie, la médecine, L E-santé, le numérique et la santé publique
Identity
- Legal form
- SAS, simplified joint-stock company
- Activity
- Research and experimental development on biotechnology (72.11Z)
- Sector
- Scientific research and development
- Headcount
- Headcount unknown
- Created
- 11 Jul 2019
- Share capital
- 4,000.00 EUR
- Registered with the trade register
- 16 Jul 2019
- Financial year end
- 31/12
- Establishments
- 1
Directors
- SYLVAIN Durrleman 72 years old, 04/1954 President de SAS
Related companies
Companies run by the same people. Statutory auditors and liquidators are excluded: they serve in dozens of unrelated companies, and including them would draw groups that do not exist.
- DALESA-04 via SYLVAIN Durrleman
- DALESANE via SYLVAIN Durrleman
- GROUPEMENT FORESTIER DES BOIS FRANCS via SYLVAIN Durrleman
Other companies at the same address
24 other company head offices are registered at this address.
Establishments
Financial strength
Financial score
62 / 100 C
Confidence: low · computed on the financial year ended 31 Dec 2020
- Equity to assets (2.6 %)
- 4.7 out of 30
- EBITDA margin (90.7 %)
- 25.0 out of 25
- Liquidity (302.1 %)
- 11.9 out of 20
- Debt (3.8 %)
- 14.4 out of 15
- Revenue trend
- data missing, component not taken into account
formula fin-1.0
Legal score
75 / 100 B
Confidence: high
- No insolvency proceedings
- 40.0 out of 40
- Currently trading
- 20.0 out of 20
- Age (7.4 years)
- 14.7 out of 20
- Accounts filed recently
- 0.0 out of 20
formula leg-1.0
These scores are computed by us from public data, using a published formula. They are not advice, not a guarantee, not a credit decision, and they do not replace a review of the accounts. See how it is calculated
Revenue and earnings
Detailed accounts for this company are not reproduced here, but its main aggregates are public.
| Financial year | Revenue | Change | EBITDA | Net income |
|---|---|---|---|---|
| 31 Dec 2020 | 115,304 € | first year on record | 104,571 € | 82,217 € |
Aggregates published by the French Directorate General for Enterprise, computed from accounts filed with the commercial court.
Explore similar companies
Legal notices
-
Filing of accounts 5 Jul 2026
- Court :
- Greffe du Tribunal des Activités Economiques de paris
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2025
BODACC C n 20260126, annonce n 10530 · Proof of publication (PDF)
-
Filing of accounts 10 Oct 2025
- Court :
- Greffe du Tribunal des Activités Economiques de paris
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2024
BODACC C n 20250195, annonce n 3785 · Proof of publication (PDF)
-
Filing of accounts 11 Aug 2024
- Court :
- Greffe du Tribunal de Commerce de paris
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2023
BODACC C n 20240155, annonce n 14891 · Proof of publication (PDF)
-
Filing of accounts 29 Oct 2023
- Court :
- Greffe du Tribunal de Commerce de paris
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2022
BODACC C n 20230209, annonce n 3203 · Proof of publication (PDF)
-
Filing of accounts 24 Jul 2022
- Court :
- Greffe du Tribunal de Commerce de paris
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2021
BODACC C n 20220142, annonce n 8386 · Proof of publication (PDF)
-
Filing of accounts 29 Mar 2022
- Court :
- Greffe du Tribunal de Commerce de paris
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2020
BODACC C n 20220062, annonce n 4040 · Proof of publication (PDF)
-
Incorporation 25 Jul 2019
- Court :
- GREFFE DU TRIBUNAL DE COMMERCE DE PARIS
BODACC A n 20190142, annonce n 1516 · Proof of publication (PDF)
Public contracts won
1 current contract
-
Institut National de la Santé et de la Recherche Medicale 49,280 € · 27 Feb 2020
Mission de conseil et d’expertise scientifique pour l’ISP
Source: essential public procurement data (DECP), Open Licence 2.0. Only the current version of each contract is shown.
Filings and annual accounts as PDF →
Change history
- Appointed: President de SAS 9 Oct 2026
- Share capital: 4,000 € 3 Oct 2026
Frequently asked questions about SOFTELMAN
- What is the SIREN number of SOFTELMAN?
- The SIREN number of SOFTELMAN is 852471036. Its intra-community VAT number is FR69852471036.
- Where is the head office of SOFTELMAN?
- Head office address: 11 RUE BONAPARTE, 75006 PARIS.
- When was SOFTELMAN founded?
- SOFTELMAN was founded on 11 Jul 2019.
- What does SOFTELMAN do?
- Its declared main activity is: Research and experimental development on biotechnology (NAF code 72.11Z).
- Who runs SOFTELMAN?
- The officer listed in the register is SYLVAIN Durrleman (President de SAS).
- What is the revenue of SOFTELMAN?
- The latest published revenue is 115,304 €, for the 2020 financial year.
- Is SOFTELMAN subject to insolvency proceedings?
- No ongoing insolvency proceedings are published in the BODACC for this company.